UCI neurobiologist Sunil Gandhi

UCI neurobiologists restore youthful vigor to adult brains

They say you can’t teach an old dog new tricks. The same can be said of the adult brain. Its connections are hard to change, while in children, novel experiences rapidly mold new connections during critical periods of brain development.

Charles Limoli

Long-term galactic cosmic ray exposure leads to dementia-like cognitive impairments

What happens to an astronaut’s brain during a mission to Mars? Nothing good. It’s besieged by destructive particles that can forever impair cognition, according to a UC Irvine radiation oncology study appearing in the May 1 edition of Science Advances.

Dr. Virginia Kimonis

Making rare diseases their common cause

Dr. Virginia Kimonis and fellow UCI researchers are dedicated to finding genetic clues, giving new hope to families

Squid skin protein could improve biomedical technologies, UCI study shows

The common pencil squid (Loliginidae) may hold the key to a new generation of medical technologies that could communicate more directly with the human body. UC Irvine materials science researchers have discovered that reflectin, a protein in the tentacled creature’s skin, can conduct positive electrical charges, or protons, making it a promising material for building biologically inspired devices.

Dr. Richard Van Etten

Leading the way for cancer cures

New Chao center director Rick Van Etten focuses on boosting patient treatments, access

Highlights of 2013 at UCI

Year brings scientific advances, national accolades, international outreach, student achievement … and zombies

The spooky side of science

In the spirit of Halloween, we offer a witches’ brew of peculiar probes and freaky findings by UCI researchers

Thomas Lane

A test of nerves

Thomas Lane leads UCI’s efforts to end the devastating effects of multiple sclerosis

Daniela Bota

Lifting the fog

Dr. Daniela Bota of UCI’s Comprehensive Brain Tumor Program is determined to find ways for cancer patients to avoid “chemo brain.”

UCI non-small cell lung cancer study highlights advances in targeted drug therapy

Lung cancer tumors stop growing, shrink or disappear in 90 percent of patients targeted drug therapy study.